Skip to main content
Equibles

VOYA INVESTMENT MANAGEMENT LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1068837 ATLANTA, GA
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$61,940
+$220 QoQ
Shares Held
54,334
+22.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 170 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $134,224,123 across 32 Drug Manufacturers - Specialty & Generic names. AKBA ranks #30 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LNTH
Lantheus Holdings, Inc.
 370,571 $41,111,146
2 NBIX
Neurocrine Biosciences Inc
 113,293 $19,094,401
3 ELAN
Elanco Animal Health Inc
 442,383 $10,887,045
4 VTRS
Viatris Inc
 471,235 $7,483,211
5 UTHR
UNITED THERAPEUTICS Corp
 13,289 $7,200,378
6 ZTS
Zoetis Inc.
 89,660 $6,442,967
7 ALKS
Alkermes plc.
 118,998 $6,235,494
8 XERS
Xeris Biopharma Holdings, Inc.
 685,570 $5,429,713

All Filings in AKBA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $61,940 54,334
2026-03-31 $61,720 44,403
2025-12-31 $74,309 46,155
2025-09-30 $126,003 46,155
2025-06-30 $251,185 69,007
2025-03-31 $108,691 56,610
2024-12-31 $121,299 63,842
2024-09-30 $92,876 70,361
2024-06-30 $73,130 71,697
2022-06-30 $106,513 301,740
2022-03-31 $89,878 125,179
2021-12-31 $282,845 125,153
2021-09-30 $332,147 115,329
2021-06-30 $403,934 106,579
2021-03-31 $370,092 109,333
2020-12-31 $273,207 97,574
2020-09-30 $212,890 84,817
2020-06-30 $615,635 45,334
2020-03-31 $443,505 58,510